Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Mounjaro , by contrast, has been moving into NHS primary care on a phased basis
Others charge separately for consultations, which can add $50-$150 per visit
Why Employers Are Paying Attention GLP-1 medications are increasingly associated with managing obesity, Type 2 diabetes, cardiovascular risk and related chronic conditions, all major drivers of employer healthcare costs
Their current estimate for global obesity drug sales by 2030 is $105 billion, down from earlier forecasts of $130 billion, based on steeper price erosion and changing customer-use patterns
US$ 20.37
US$ 29.27
US$ 29.34
US$ 27.59
